A STUDY OF USE OF DMPA( INJECTABLE CONTRACEPTIVE) IN POSTPARTUM AND POSTABORTAL PATIENTS.
Dr. Abhipsa Patel, Dr Jigar Thakkar, Dr Megha S Patel, Dr Saila Altaf Khatri
Background:Injectable depot-medroxyprogesterone acetate is a progestin-only, long acting contraceptive. It is proved safe, effective, reversible and acceptable.Aims and Objective:The objective of the study is to evaluate the safety and effectiveness of DMPA, its acceptance and its side effects in postpartum and postabortal women.Materials and method:The type of study was prospective, interventional, longitudinal and a single centered study conducted in Department of Obstetrics and Gynecology at L G Hospital, Maninagar, Ahmedabad.Study group received Inj. DMPA 150 mg intra muscularly immediately after abortion and delivery before discharge from hospital (Day 2 to 7 of their delivery). They were given DMPA every 3 months.Results:In present study out of 90 patients,50 patients (55.55%) took injection post-delivery and 40 patients (44.44%) took it post abortion.Irregular bleeding was major side effect seen in 55 patients (61.11%), amenorrhea seen in 26 (29%) patients, weight gain noted in 3 patients over 1 year, other side effects were headache, backache, dyspareunia, erythema nodosum in 5 patients.In post-partum women, lactation remained unaffected.Conclusion:Patients prefer DMPA because it is non-coitus dependent, convenient, long acting and other non-contraceptive benefits.No effect on lactation.The return of fertility takes 7-10 months from date of last injection, but it is completely reversible.
Cite This Article:
Download PDF Number of Downloads : 37